Drug-induced gynecomastia;Les gynecomasties medicamenteuses

Annales de Medecine Interne

Volumn 151, Issue 1, 2000, Pages 10-17

  Hugues, François Claude ^a   Gourlot, Catherine ^a   Le Jeunne, Claire ^a  

^a Hopital Laennec   (France)

Author keywords

Drug causality; Drug side effects; Gynecomastia

Indexed keywords

ALKYLATING AGENT; ANTIANDROGEN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANRENOIC ACID; CAPTOPRIL; CIMETIDINE; DIAZEPAM; DIETHYLSTILBESTROL; DIGITALIS GLYCOSIDE; ESTRADIOL; ESTROGEN DERIVATIVE; FINASTERIDE; FOSFESTROL; GONADORELIN DERIVATIVE; GONADOTROPIN DERIVATIVE; GOSERELIN; GROWTH HORMONE; HALOPERIDOL; LEUPRORELIN; MINOCYCLINE; NEUROLEPTIC AGENT; NIFEDIPINE; OMEPRAZOLE; SPIRONOLACTONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTORELIN; UNINDEXED DRUG; VERAPAMIL; ANDROGEN; CARDIOVASCULAR AGENT; ESTROGEN; GASTROINTESTINAL AGENT; PROLACTIN; PSYCHOTROPIC AGENT; SEX HORMONE;

ANDROGEN BLOOD LEVEL; DRUG INDUCED DISEASE; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; GYNECOMASTIA; HUMAN; PATHOGENESIS; REVIEW; TESTOSTERONE SYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; MALE;

ANDROGEN ANTAGONISTS; ANDROGENS; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR AGENTS; ESTROGENS; GASTROINTESTINAL AGENTS; GONADAL STEROID HORMONES; GYNECOMASTIA; HUMANS; MALE; PROLACTIN; PSYCHOTROPIC DRUGS;

EID: 0034136720     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. BRAUSTEIN G. Gynaecomastia. N Engl J Med, 1993; 328: 490-5.
2. BÉGAUD B, ÉVREUX J-C, JOUGLARD J, LACIER G. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie, 1985 ; 40 : 111-8.
3. GREEN L, WYSOWSKI D, FOURCROY J. Gynaecomastia and breast cancer during finasteride therapy. N Engl J Med, 1996; 335: 823.
4. WILTON L, EDEN E, PEARCE G, FREEEMANTLE S, STEPHENS M, MANA R. The effects of finasteride used in benign prostatic hypertrophy: A non interventionnal cohort study in 14772 patients. Br J Urol 1996; 78: 379-84.
5. BROWN W, LAUGHREN T. Tolerance to the prolactin elevating effect of neuroleptics. Psychiatr Res, 1981; 5: 317-22.
6. MŒRCK HJ, MAGELUNG G. Gynaecomastia and diazepam. Lancet 1979; i: 1344-5.
7. BERGMAN D, FUTTERWEIT W, SEGAL R, SIROTA D. Increased œstradiol in diazepam related gynaecomastia. Lancet, 1981; ii: 1225-6.
8. HUFFMAN D, KAMPMANN JP, HIGNITE C, AZANOFF DL: Gynaecomastia induced in normal males by spironolactone. Clin Pharmacol Ther, 1978; 24. 465-73.
9. JEUNEMAITRE X, CHATELLIER G, CHARRU A, et al.: Efficacy and tolerance of spironolactone in essential hypertension. Kidney Int. 1998; 34. S14-8.
10. DUPONT A: Disappearance of spironolactone induced gynaecomastia during treatment with potassium canrenoate. Lancet, 1985; i. 731.
11. BELLATI G, IDEO G. Gynaecomastia after spironolactone and potassium canréonate. Lancet, 1986; i: 626.
12. ANN TANNER L, BOSCO LA. Gynaecomastia associated with calcium channel blocker therapy. Arch Intern Med, 1988; 148: 378-80.
13. ZOCHLING J, LARGE G, FASSET R. Gynaecomastia and amlodipine. Med J Austral, 1994; 160: 807.
14. MAESTRI E, CAMELLINI L, ROSSI G. Effects of five days verapamil administration on serum GH and PRL levels. Horm Metabol Res, 1985; 17: 482-5.
15. LEWIN EB. Gynaecomastia during digitalis therapy. N Engl J Med 1953; 248: 316-20.
16. BURCKHARD D, VERA C, LADUE J. Effect of digitalis on urinary pituitary gonadotrophin excretion. Ann Intern Med, 1968; 68: 1069-71.
17. NAKAMURA Y, YOSHIMITO S, SAIMA J. Gynaecomastia induced by angiotensin inhibitors. Br med J, 1990; 300: 541.
18. THOMPSON D, CARTER J. Drug-induced gynaecomastia. Pharmacother, 1993; 13: 37-45.
19. JENSEN R, COLLEN M, PANDOL S, ALLENDE H, RAUFMAN JP. Cimetidine induced impotence and breast changes in patients with gastric hypersecretory states. N Engl J Med, 1983; 308: 883-7.
20. BERA F, JONVILLE A, DOUSTIN P, AUTRET E. Impuissance et gynécomasties secondaires à une hyperprolactinémie induite par la ranitidine. Thérapie, 1994 ; 49 : 355-6.
21. MIGNON M, VALLOT T, BONFILS S. Gynaecomastia and histamine H2 antagonists. Lancet, 1992; ii: 499.
22. LINDQUIST M, RALPH EDWARDS I. Endocrine adverse effects of omeprazole. Br Med J, 1992; 305: 451-2.
23. CONVENS C, VERHELST J, MAHLER C. Painful gynecomastia during omeprazole therapy. Lancet, 1991; 338: 1153.
24. DURAND JM, CRETEL E, KAPLANSKI G, SOUBEYRAND J. Gynécomastie et traitement prolongé par l'oméprazole. Rev Med Interne, 1993 ; 14 : 139.
25. GARCIA-RODRIGUEZ L, JICK H. Risk of gynaecomastia associated with cimetidine, omeprazole and other antiulcer drugs. Br Med J, 1994; 308: 503-6.
26. KEATING JP, REES M. Gynecomasria after long term administration of domperidone. Postgrad Med J, 1991; 67: 401-4.
27. DAVIS JP: Minocycline side-effects. Br J Clin Pract, 1995; 49: 179.
28. MAC GOWAN A, REEVES D, WRIGHT C, GLOVER S. Tricuspid valve infective endo carditis and pulmonary sepsis due to Erysipelothrix rhusiopathiae successfully treated with high doses of ciprofloxacin but complicated by gynaecomastia. J Infect, 1991; 22: 100-1.
29. BROUET G, MARCHE J. Les complications d'ordre métabolique et endocrinien produites par la chimiothérapie antibacillaire. Rev Tub Pneumol, 1964 ; 28 : 5-71.
30. MALOZOWSKI S. Gynaecomastia. N Engl J Med, 1993; 329: 209.
31. PONT A, GRAYBILL J, CRAVEN P, et al. The effect of high dose ketoconazole on adrenal and testicular function. Arch Intern Med 1984; 144: 2150-3.
32. YESHURUN D, ABUKARSHIN R, ELLIAS N, NASCHITZ J. Long-term bezafibrate treatment in a lipidic clinic. Harefuah, 1992; 122: 632-4.
33. HANDS L, GREENAL M. Gynaecomastia. Br J Surg, 1991; 78: 907-11.
34. MURRAY NP, DALY MJ. Gynecomastia and heart failure adverse drug reaction or disease process? J Clin Pharmacol Ther, 1991; 16: 275-9.
35. COHN L, FELLER AG, DRAPER MW, RUDMAN IW, RUDMAN D. Carpal tunnel syndrome and gynecomastia during growth hormone treatment of elderly men with low circulating IGF1 concentrations. Clin Endocrinol, 1993; 39: 417-25.
36. HELL K, WERNZE H. Drug induced changes in prolactin secretion. Clinical implications. Medical Toxicol, 1988; 3: 463-98.